tradmap

Overbought Stocks — Overview View · Biological Products, (No Diagnostic Substances)

8 stocks match the Overbought Stocks screen. Stocks with an RSI (14) above 70 — technically overbought, most-overbought first. Overview columns. Filtered to Biological Products, (No Diagnostic Substances). Updated

Filters2
1–8 of 8
TARSTarsus Pharmaceuticals, Inc.HealthcareBiological Products, (No Diagnostic Substances)$3.6B-78.4883.12+0.41%Buy43K
APGEApogee Therapeutics, Inc.HealthcareBiological Products, (No Diagnostic Substances)$10.2B-34.57135.08+0.04%Buy89K
ALVOAlvotechHealthcareBiological Products, (No Diagnostic Substances)5.37+0.56%Buy74K
HALOHalozyme Therapeutics, Inc.HealthcareBiological Products, (No Diagnostic Substances)$12.6B30.39110.73+1.01%Buy90K
ATTOAttovia Therapeutics, Inc.HealthcareBiological Products, (No Diagnostic Substances)$1.2B25.33+3.56%Neutral23K
NVAXNovavax IncHealthcareBiological Products, (No Diagnostic Substances)$1.7B-6.8810.34+0.19%Buy229K
CRDLCardiol Therapeutics Inc.HealthcareBiological Products, (No Diagnostic Substances)2.15-0.23%Strong Buy66K
IOVAIovance Biotherapeutics, Inc.HealthcareBiological Products, (No Diagnostic Substances)$4.0B-13.778.80+2.09%Buy641K

Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.